Login / Signup

Safety, activity, and long-term outcomes of pomalidomide in the treatment of Kaposi sarcoma among individuals with or without HIV infection.

Ramya RamaswamiMark N PolizzottoKathryn LurainKathleen M WyvillAnaida WidellJomy GeorgePriscila GoncalvesSeth M SteinbergNazzarena LaboThomas S UldrickRobert Yarchoan
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Pomalidomide is a safe and active chemotherapy-sparing agent for the treatment of KS among individuals with or without HIV.
Keyphrases
  • antiretroviral therapy
  • multiple myeloma
  • human immunodeficiency virus
  • hepatitis c virus
  • hiv positive
  • combination therapy
  • radiation therapy
  • hiv testing
  • robot assisted
  • replacement therapy